Journals / Turkish Journal of Chemistry / 2014 / Cilt: 38 - Sayı: 6

Boron-containing tetrapyrroles

Pages
950–979
Publication Date
2014-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.
📊
Key Findings & Data:The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.
💡
Conclusion & Impact:The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Porphyrins · porphyrazines · phthalocyanines

Abstract

The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.

Özet

The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins, porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.

🔖

Cite This Article

ÖZÇELİK, Ş., GÜL, A. (2014). Boron-containing tetrapyrroles. Turkish Journal of Chemistry, Cilt: 38 - Sayı: 6, 950–979. https://ajindex.com/articles/184683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Ali, H.; van Lier, J. E. Chem. Rev. 1999, 99, 2379–2450.
  2. Pietrangeli, D.; Rosa, A.; Ristori, S.; Salvati, A.; Altieri, S.; Ricciardi, G. Coordin. Chem. Rev. 2013, 257, 2213– 2231. Guillaud, G.; Simon, J.; Germain, J. P. Coordin. Chem. Rev. 1998, 178–180, 1433–1484.
  3. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. J. Natl. Cancer Inst. 1998, 90, 889–905.
  4. Lovel, J. F.; Liu, T. W. B.; Chen, J.; Zheng G. Chem. Rev. 2010, 110, 2839–2857.
  5. Camerin, M.; Magaraggia, M.; Soncin, M.; Jori, G.; Moreno, M.; Chambrier, I.; Cook, M. J.; Russell, D. A. Eur. J. Cancer 2010, 46, 1910–1918.
  6. Grimes, R. N. Carboranes; Academic Press:
  7. San Diego, CA, USA, 2011.
  8. Barth, R. F.; Coderre, J. A.; Vicente, M. G.; Blue, T. E. Clin. Cancer Res. 2005, 11, 3987–4002.
  9. Hawthorne, M. F. Angew. Chem. Int. Ed. Eng. 1993, 32, 950–984.
  10. Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F. G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. Chem. Rev. 1998, 98, 1515–1562. 11.Barth, R. F.; Soloway, A. H.; Goodman, J. H.; Gahbauer, R. A.; Gupta, N.; Blue, T. E.; Yang, W. L.; Tjarks, W. Neurosurgery 1999, 44, 433–451. 12.Sibrian-Vazquez, M.; Vicente, M. G. H. In Boron Science: New Technologies and Applications; Hosmane, N. S., Ed. CRC Press:
  11. Boca Raton, FL, USA, 2011, pp. 209–242. 13.Barth, R. F.; Joensuu, H. Rad. Oncol. 2007, 82, 119–122. 14.Bregadze, V. I.; Sivaev, I. B.; Gabel, D.; W¨ohrle, D. J. Porphyr. Phthalocya. 2001, 5, 767–781.
  12. Sivaev, I. B.; Bregadze, V. I.; G¨ul, A.; Mironov, A. F. Macroheterocycles 2012, 5, 292–301. 16.Pandey, R. K.; Zhang, G. In The Porphyrin Handbook; Kadish, K. M.; Smith, K. M.; Guilard, R., Eds. Academic Press:
  13. Boston, MA, USA, 2002, pp. 157–230.
  14. Brown, S.; Brown, E. A.; Walker, I. Lancet Oncol. 2004, 5, 497–508.
  15. Huang, Z. Techn. Cancer Res. Treat. 2005, 4, 283–293. 19.Sibrian-Vasquez, M.; Hao, E.; Jensen, T. J.; Vicente, M. G. H. Bioconjug. Chem. 2006, 17, 928–934.
  16. Hawthorne, M. F. Mol. Med. Today 1998, 4, 174–181.
  17. Bhupathiraju, N. V. S. D. K.; Vicente, M. G. H. Bioorg. Med. Chem. 2013, 21, 485–495.
  18. Wu, H.; Micca, P. L.; Makar, M. S.; Miura, M. Bioorgan. Med. Chem. 2006, 14, 5083–5092.
  19. Clark, J. C.; Fronczek, F. R.; Vicente, M. G. H. Tetrahedron Lett. 2005, 46, 2365–2368.
  20. Gottumukkala, V.; Luguya, R.; Fronczek, F. R.; Vicente, M. G. H. Bioorgan. Med. Chem. 2005, 13, 1633–1640.
  21. Ongayi, O.; Gottumukkala, V.; Fronczek, F. R.; Vicente, M. G. H. Bioorg. Med. Chem. Lett. 2005, 15, 1665–1668.
  22. Gottumukkala, V.; Ongayi, O.;